Daily as of 3 Nov 16:00 ET
- Price
- below both $4.09 vs 50 $4.74 / 200 $5.32
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 14 Oct 2026 · projected 22 bars out
TSHA | Taysha Gene TherapiesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$4.09
+$0.09 (+2.25%)
Taysha Gene Therapies (TSHA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $4.13 vs 50 $5.26 / 200 $2.90
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 17 Nov 2025 · projected 17 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $4.09 vs 50 $4.16 / 200 $5.44
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 3 Sep 2026 · projected 5 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 14 Oct 2026 | 💀Death moderate | daily | 22 bars out | Not tested |
| 3 Sep 2026 | 💀Death | 4-hour | 5 bars out | Not tested |
| 23 Apr 2026 | 🟨Golden | 4-hour | 18 bars out | Not tested |
| 13 Feb 2026 | 💀Death | 4-hour | 28 bars out | 4 bar cross test |
| week of 17 Nov 2025 | 🟨Golden moderate | weekly | 17 bars out | Not tested |
About TSHA
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$15.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall